[1] |
HE Yang, YANG Kui, LUAN Jiajie.
Effects of CDA-G208A gene polymorphism on the efficacy of gem-citabine in the first-line treatment of lung squamous cell carcinoma
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 299-306.
|
[2] |
GAO Lili, WANG Yuzhu, WANG Yan, LI Jian, WANG Jun.
General considerations for clinical pharmacology of antitumor antibody-conjugated drugs: Implications from FDA review cases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 75-85.
|
[3] |
JIANG Yuhua, ZHI Hui, LU Linming, TIAN Dahao, WANG Xiaoqing, GE Yu, XIE Shangfu, WANG Qi.
AHVAC-I reverses tumor growth of cancer-associated fibroblasats in gastric cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(4): 389-394.
|
[4] |
XIE Rongrong, CHEN Zhi, YANG Yu, XIE Raoying, LI Pingping, SUN Shuangshuang, CHEN Wenjun.
Treatment strategies of FGFR molecular alterations in lung squamous cell carcinoma
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(2): 196-203.
|
[5] |
TIAN Yali, FENG Lin, ZHAO Wan, GU Min, SHEN Hanjing, CHAI Xiaoyan.
Correlation of BRCA1 gene polymorphism with chemosensitivity and prognosis of metastatic esophageal squamous cell carcinoma treated with cisplatin combined with capecitabine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(10): 1118-1126.
|
[6] |
FAN Wenbin, WANG Chunrong, CHEN Kailin, LUO Jingwen.
Study on active components and molecular mechanisms of Ilex Kudingcha in the prevention and treatment of esophageal squamous cell carcinoma by network pharmacology
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(8): 880-888.
|
[7] |
XING Han, NING Chen, KONG Dexuan, CAI Hui, ZHOU Shiyu, REN Chang, KONG Ying, CHENG Yujie, CHEN Xijing.
Tissue distribution and excretion study of GL-V9 in rats, a wogonin derivative with significant antitumor activity
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(8): 889-895.
|
[8] |
LI Hongli, WEN Dandan, ZHOU Meiliang, WANG Haihua, PENG Xixu, GAO Lichen.
Advances in extraction and mechanism of antitumor active components from Fagopyrum dibotrys
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(7): 833-840.
|
[9] |
GUO Li, HAN Chenyang.
Preparation of piperine liposomes and its antitumor activity of gastric cancer cells in vitro
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(11): 1240-1245.
|
[10] |
MA Chenghua, ZHOU Haijing, SHI Wen, WANG Zhiqiang, YANG Lan, CHEN Ping, ZHENG Xueli, MA Rui, MA Lijuan.
Mechanism of apoptosis of mucoepidermoid carcinoma MEC-1 cells induced by ethanol extract of Lamiophlomis rotate
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(3): 253-259.
|
[11] |
YAO Tianyi, YIN Shaoping, LIU Wen, ZHAO Yanlei, WANG Guangji, LI Juan.
Biodistribution and biological evaluation of paclitaxel polymer micelles
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(11): 1207-1214.
|
[12] |
TAO Shao-Neng, WANG Ying-Ying, ZHOU Jian-Guo, CHENG Guang-Hua, ZHANG Meng-Ying, ZHONG Min, 吕Kun .
Inhibition effects of methotrexate enantiomers on the growth of human lung cancer A549 cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(6): 625-630.
|
[13] |
LI Zhao-fa, WANG Cong-yang, DENG Xiao-ying, HUI Er-jing.
Infusion receptor eDR4/iFas enhances TRAIL-induced apoptosis of HT-29 cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(9): 966-972.
|
[14] |
SHANG Li-na, HONG Ming-yue.
Recent progresses on antibody-targeted conjugates of antitumor antibiotics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(9): 1075-1080.
|
[15] |
YANG Jian, YANG Qian.
Advances in pharmacological research of 8-methoxypsoralen
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(10): 1177-1182.
|